Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism.
Saved in:
| Title: | Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism. |
|---|---|
| Authors: | Nowotny HF; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Zheng T; Chair of Translational Microbiome Data Integration, Technical University of Munich, Freising, Germany., Seiter TM; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Ju J; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Schneider H; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Kroiss M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Sarkis AL; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Sturm L; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Britz V; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Lechner A; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Potzel AL; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Physicians Association for Nutrition e.V, Munich, Germany.; CCG Type 2 Diabetes, Helmholtz Zentrum München, Munich, Germany., Kunz S; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Bidlingmaier M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Neuhaus K; Core Facility Microbiome, ZIEL - Institute for Food & Health, Technical University of Munich, Freising, Germany., Gottschlich A; Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University Hospital LMU, Munich, Germany., Kobold S; Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University Hospital LMU, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany., Reisch N; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Schirmer M; Chair of Translational Microbiome Data Integration, Technical University of Munich, Freising, Germany., Reincke M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Adolf C; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Dec 19; Vol. 15, pp. 1428054. Date of Electronic Publication: 2024 Dec 19 (Print Publication: 2024). |
| Publication Type: | Journal Article; Clinical Trial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1428054 |
